Related Experiment Video
Updated: Jul 2, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection
Yumiko Ishii1, Tomoko Nakae, Fumiko Sakamoto
1Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
A novel hydrogel patch offers a simple, noninvasive method for transcutaneous vaccination. This vaccination system effectively induces immune responses and shows potential for global vaccine distribution.
Area of Science:
- Immunology
- Biomaterials Science
- Public Health
Background:
- Preventing infectious disease spread is crucial, but vaccine accessibility in developing nations remains a challenge.
- Current vaccination methods can be invasive and require specialized administration, limiting their reach.
Purpose of the Study:
- To develop and evaluate a simple, noninvasive hydrogel patch for transcutaneous vaccination.
- To assess the immunogenicity and efficacy of the hydrogel patch vaccination system in preclinical models.
Main Methods:
- A hydrogel patch was immersed in antigen and applied to mouse or rat skin without pretreatment.
- Immunofluorescence histochemistry was used to track antigen-capturing Langerhans cells and their migration.
- Humoral immunity was evaluated through adenoviral infection and tetanus toxin neutralization assays.
Main Results:
- Transcutaneous vaccination using the hydrogel patch successfully induced antigen-specific IgG production.
- Langerhans cells in the epidermis captured antigens, facilitated by the hydrogel patch's penetration through the stratum corneum.
- Migrating Langerhans cells reached draining lymph nodes, initiating a humoral immune response with neutralizing activity.
Conclusions:
- The hydrogel patch transcutaneous vaccination system is a viable, noninvasive method for inducing humoral immunity.
- This innovative system demonstrates potential for overcoming barriers to vaccine distribution and administration globally.
- The technology facilitates antigen delivery and immune cell migration, paving the way for convenient and effective vaccination strategies.
Related Concept Videos
Transdermal Drug Delivery Systems
Vaccinations
Vaccines
Modified-Release Drug Delivery Systems: Stimuli-Activated
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
